$3.00
-0.10-3.23%
Last update: Nov 6, 4:00 PM
Intensity Therapeutics Inc
INTSNASDAQ
Intensity Therapeutics (INTS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.98 | $-0.78 | $-1.14 | $-1.29 |
| Actual | $-1.09 | $-1.11 | $-0.96 | $-1.31 |
| Surprise | -11.2% | -42.3% | +15.8% | -1.55% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | — | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.67 | $-0.45 | $-0.22 | $-0.22 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $-1.09 | $-0.98 | -11.2 % |
| Q2 | Aug 11, 2026 | $-1.11 | $-0.78 | -42.3 % |
| Q1 | May 7, 2026 | $-0.96 | $-1.14 | 15.8 % |
| Q4 | Mar 27, 2026 | $-1.31 | $-1.29 | -1.55 % |
